Nitric Oxide Synthase Inhibitors as Antidepressants
Affective and anxiety disorders are widely distributed disorders with severe social and economic effects. Evidence is emphatic that effective treatment helps to restore function and quality of life. Due to the action of most modern antidepressant drugs, serotonergic mechanisms have traditionally bee...
Main Authors: | Vallo Volke, Gregers Wegener |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-01-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/1/273/ |
Similar Items
-
Expression of monoamine transporters, nitric oxide synthase 3 and neurotrophin genes in antidepressant-stimulated astrocytes
by: Sarah eKittel-Schneider, et al.
Published: (2012-04-01) -
RETRACTED – Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
by: Atsuko Ikenouchi, et al.
Published: (2022-01-01) -
Nitric Oxide (NO) Synthase Inhibitors: Potential Candidates for the Treatment of Anxiety Disorders?
by: Nikolaos Pitsikas
Published: (2024-03-01) -
The Involvement of Nitric Oxide in Antidepressant-Like Effect of Metformin after Bile-Duct Ligation in NMRI Mice
by: Sattar Ostadhadi, et al.
Published: (2015-10-01) -
Selective nitric oxide synthase inhibitor promotes bone healing
by: Ali Reza Farhad, et al.
Published: (2017-01-01)